Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravindran Ankathil

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2019
Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control StudyRavindran Ankathil, Mohd Aminudin Mustapha, Ahmad Aizat Abdul Aziz, et al.
Frontiers in Oncology|August 25, 2022
Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylateIsmail Siti Mariam, Ramli Norhidayah, Abu Bakar Zulaikha, et al.
Biomed Research International|October 16, 2020
Screening of 22q11.2DS Using Multiplex Ligation-Dependent Probe Amplification as an Alternative Diagnostic MethodSathiya Maran, Siti Aisyah Faten, Swee-Hua Erin Lim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2021
Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia PatientsAziati Azwari Annuar, Ravindran Ankathil, Nazihah Mohd Yunus, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2012
Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian populationAbdul Aziz Ahmad Aizat, Siti Nurfatimah Mohd Shahpudin, Mohd Aminudin Mustapha, et al.
Cancer Epidemiology|June 29, 2013
The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancerMohd Shafi'i Mohd Suzairi, Shing Cheng Tan, Abdul Aziz Ahmad Aizat, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patientsZahary Mohd Nizam, Ahmad Aizat Abdul Aziz, Gurjeet Kaur, et al.
Journal of Genetics|December 18, 2018
Single-nucleotide polymorphisms and mRNA expression of <i>CYP1B1</i> influence treatment response in triple negative breast cancer patients undergoing chemotherapyAhmad Aizat Abdul Aziz, Md Salzihan Md Salleh, Ibtisam Mohamad, et al.
Journal of Experimental Therapeutics & Oncology|December 11, 2008
Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative casesVani Syamala, Volga S Syamala, Leelakumari Sreeja, et al.
Medical Oncology (Northwood, London, England)|September 3, 2013
Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancerShing Cheng Tan, Mohd Shafi'i Mohd Suzairi, Abdul Aziz Ahmad Aizat, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2019
Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control StudyRavindran Ankathil, Mohd Aminudin Mustapha, Ahmad Aizat Abdul Aziz, et al.
Frontiers in Oncology|August 25, 2022
Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylateIsmail Siti Mariam, Ramli Norhidayah, Abu Bakar Zulaikha, et al.
Biomed Research International|October 16, 2020
Screening of 22q11.2DS Using Multiplex Ligation-Dependent Probe Amplification as an Alternative Diagnostic MethodSathiya Maran, Siti Aisyah Faten, Swee-Hua Erin Lim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2021
Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia PatientsAziati Azwari Annuar, Ravindran Ankathil, Nazihah Mohd Yunus, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2012
Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian populationAbdul Aziz Ahmad Aizat, Siti Nurfatimah Mohd Shahpudin, Mohd Aminudin Mustapha, et al.
Cancer Epidemiology|June 29, 2013
The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancerMohd Shafi'i Mohd Suzairi, Shing Cheng Tan, Abdul Aziz Ahmad Aizat, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patientsZahary Mohd Nizam, Ahmad Aizat Abdul Aziz, Gurjeet Kaur, et al.
Journal of Genetics|December 18, 2018
Single-nucleotide polymorphisms and mRNA expression of <i>CYP1B1</i> influence treatment response in triple negative breast cancer patients undergoing chemotherapyAhmad Aizat Abdul Aziz, Md Salzihan Md Salleh, Ibtisam Mohamad, et al.
Journal of Experimental Therapeutics & Oncology|December 11, 2008
Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative casesVani Syamala, Volga S Syamala, Leelakumari Sreeja, et al.
Medical Oncology (Northwood, London, England)|September 3, 2013
Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancerShing Cheng Tan, Mohd Shafi'i Mohd Suzairi, Abdul Aziz Ahmad Aizat, et al.
Pageof 6